West Pharmaceutical Servi... (WST)
NYSE: WST
· Real-Time Price · USD
246.62
0.42 (0.17%)
At close: Aug 15, 2025, 3:03 PM
West Pharmaceutical Services Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.96B | 2.9B | 2.89B | 2.88B | 2.88B | 2.93B | 2.95B | 2.93B | 2.87B | 2.88B | 2.89B | 2.91B | 2.93B | 2.88B | 2.83B | 2.68B | 2.52B | 2.33B |
Cost of Revenue | 1.92B | 1.89B | 1.89B | 1.87B | 1.85B | 1.84B | 1.82B | 1.81B | 1.77B | 1.76B | 1.75B | 1.73B | 1.73B | 1.69B | 1.66B | 1.59B | 1.53B | 1.45B |
Gross Profit | 1.04B | 1B | 998.5M | 1B | 1.03B | 1.09B | 1.13B | 1.11B | 1.09B | 1.12B | 1.14B | 1.17B | 1.19B | 1.19B | 1.18B | 1.09B | 992.7M | 872.7M |
Operating Income | 586.1M | 554.1M | 569.9M | 571.2M | 587.2M | 643.5M | 676M | 644.8M | 653.7M | 699.6M | 734M | 788.3M | 783.5M | 766.4M | 752.3M | 684.4M | 602.2M | 494.5M |
Interest Income | 17.1M | 17.5M | 19.6M | 24.2M | 28.4M | 29.4M | 28M | 21.5M | 14.2M | 9.6M | 5.1M | 2.5M | 1.4M | 1.2M | 1M | 900K | 700K | 700K |
Pretax Income | 611.2M | 582.4M | 600.2M | 604.8M | 627.1M | 683.8M | 715.7M | 676.1M | 626.4M | 669.2M | 700.6M | 750.6M | 790.7M | 769M | 748.9M | 682.1M | 598.7M | 489.7M |
Net Income | 487.7M | 467.2M | 492.7M | 499.6M | 524.9M | 568.7M | 593.4M | 559.4M | 518.7M | 552.1M | 585.9M | 630.6M | 685.6M | 684.4M | 661.8M | 612.5M | 519.2M | 423.1M |
Selling & General & Admin | 352.7M | 339.8M | 338.5M | 343.2M | 348.7M | 354.1M | 353.4M | 349.1M | 326.4M | 319.5M | 316.9M | 329.2M | 354.8M | 366M | 362.8M | 341.1M | 325.4M | 310.4M |
Research & Development | 69.4M | 67.8M | 69.1M | 69M | 69.9M | 68.9M | 68.4M | 65.9M | 63.1M | 61M | 58.5M | 56.3M | 55.8M | 55.2M | 52.8M | 52M | 51.4M | 48.4M |
Other Expenses | 35.2M | 38.5M | 21M | 19.7M | 20.9M | 21.6M | 31.4M | 53.3M | 49.6M | 42.8M | 26.8M | 900K | 800K | 900K | 7.9M | 8.8M | 13.7M | 19.4M |
Operating Expenses | 457.3M | 446.1M | 428.6M | 431.9M | 439.5M | 444.6M | 453.2M | 468.3M | 439.1M | 423.3M | 402.2M | 386.4M | 411.4M | 422.1M | 423.5M | 401.9M | 390.5M | 378.2M |
Interest Expense | 400K | 1.8M | 3M | 5M | 7.2M | 8.4M | 9M | 9.5M | 8.8M | 7.9M | 7.9M | 8.8M | 8.4M | 8.5M | 8.2M | 7.7M | 8M | 8.1M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.37B | 2.34B | 2.32B | 2.31B | 2.29B | 2.29B | 2.27B | 2.28B | 2.21B | 2.18B | 2.15B | 2.12B | 2.15B | 2.11B | 2.08B | 2B | 1.92B | 1.83B |
Income Tax Expense | 123.5M | 115.2M | 107.5M | 105.2M | 102.2M | 115.1M | 122.3M | 116.7M | 107.7M | 117.1M | 114.7M | 120M | 111.6M | 99.7M | 107.2M | 93.4M | 102.5M | 86.2M |
Shares Outstanding (Basic) | 72.3M | 72.5M | 73M | 72.8M | 73M | 73.5M | 74.1M | 74.3M | 74.3M | 74.5M | 74.4M | 74.4M | 74.4M | 74.4M | 74.5M | 74.1M | 74M | 73.9M |
Shares Outstanding (Diluted) | 72.8M | 73M | 73.7M | 73.4M | 73.7M | 74.3M | 75M | 75.3M | 75.4M | 75.7M | 75.6M | 75.7M | 75.8M | 76M | 76.4M | 76M | 75.7M | 75.8M |
EPS (Basic) | 6.72 | 6.42 | 6.75 | 6.81 | 7.11 | 7.68 | 7.99 | 7.52 | 6.97 | 7.41 | 7.87 | 8.47 | 9.22 | 9.22 | 8.92 | 8.27 | 7.01 | 5.72 |
EPS (Diluted) | 6.68 | 6.37 | 6.69 | 6.74 | 7.03 | 7.58 | 7.88 | 7.41 | 6.86 | 7.29 | 7.73 | 8.30 | 9.02 | 9.00 | 8.70 | 8.06 | 6.84 | 5.58 |
EBITDA | 759.6M | 729.5M | 743.2M | 743.7M | 763.9M | 816.7M | 843.8M | 800M | 741.8M | 776.9M | 804.2M | 861.6M | 907.1M | 892.5M | 879.4M | 806.6M | 721.9M | 610.4M |
EBIT | 597.3M | 570.4M | 588.5M | 593.8M | 618.5M | 675.9M | 707M | 668M | 616.5M | 655.1M | 685M | 739.1M | 783.6M | 770.3M | 757.1M | 689.8M | 606.7M | 497.8M |
Depreciation & Amortization | 162.3M | 159.8M | 155.4M | 150.6M | 146.1M | 141.3M | 137.3M | 132.5M | 126.6M | 122.6M | 120.6M | 123.9M | 124.1M | 122.8M | 122.3M | 116.4M | 114.8M | 112.2M |